logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Nonfatal adverse reactions to iodinated contrast media : Spontaneous reporting to the U.S. food and Drug administration, 1978-1994.

    Article - En anglais

    PURPOSE 

    To identify any changes in the frequency of serious, nonfatal adverse drug events (ADEs) reported to the U.S. Food and Drug Administration in 1978-1994 since the introduction of low-osmolality contrast media (LOCM).

    MATERIALS AND METHODS 

    Reports of ADEs submitted were reviewed for use of iodinated contrast media.

    RESULTS 

    The estimated 170 million contrast medium-enhanced radiologic studies performed in 1978-1994 produced 22,785 reports of mild or moderate ADEs, 2,639 reports of serious but nonfatal ADEs, and 920 reports of death.

    The most common ADEs (urticaria, dyspnea, vomiting, pruritus, facial edema, and hypotension) ranked similarly for ionic and nonionic contrast media.

    High-osmolality contrast media were associated with 512 serious, nonfatal ADEs reported in 1978-1986 ; 1,068 were reported in 1987-1994.

    Nonionic LOCM were associated with 17 serious, nonfatal ADEs reported in 1978-1986 ; 609 were reported in 1987-1994.

    Intrathecal injection of nonionic contrast media was associated with 235 reported serious, nonfatal ADEs ; intrathecal contrast media were associated with 14 such reported ADEs.

    CONCLUSION 

    Reports of serious, nonfatal ADEs are uncommon relative to the use of contrast media.

    The authors observed no decrease in the number of ADEs reported since the introduction of LOCM but did not consider marketing trends or secular reporting trends.

    Mots-clés Pascal : Produit contraste, Iode, Médicament, Surveillance sanitaire, Toxicité, Symptomatologie, Homme, Epidémiologie, Etats Unis, Amérique du Nord, Amérique, Radiodiagnostic

    Mots-clés Pascal anglais : Contrast media, Iodine, Drug, Sanitary surveillance, Toxicity, Symptomatology, Human, Epidemiology, United States, North America, America, Radiodiagnosis

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0416218

    Code Inist : 002B02U10. Création : 19/12/1997.